ReviewAdvances in therapy2023

Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy.

Jerome Goldschmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.